NCM-32257-84103
3 vaccinations
3 coded responses
20 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 12-15
- ZIP prefix
- 774 / TX
- Registered
- 2021-11-12
- Relationship
- Child or adolescent in my care
- Guardian
- 2L8-28733-37969
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-12
Registered in v-safe
-
2021-11-12
Dose 1 — Pfizer-BioNTech
- 2021-11-12
-
2021-11-13
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Abdominal pain upper — Feeling: Good · Site: Pain · Chills, Headache, Nausea · Be unable to do your normal daily activitiesFree text: StomachacheMedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-11-15
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-11-16
- 2021-11-18
- 2021-11-20
-
2021-11-27
Survey response — day 14, dose 1, dependentMedDRA: Headache, Vomiting — Feeling: GoodFree text: Headaches and vomiting.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-05
- 2021-12-07
- 2021-12-08
- 2021-12-11
- 2021-12-20
- 2021-12-25
- 2022-01-02
- 2022-01-08
- 2022-01-17
-
2022-03-07
Survey response — 3 months, dose 2, dependentMedDRA: Dehydration, Emergency care, Syncope — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Dehydration and fainting · Healthcare visit (other): Paramedics checked her and advised to take her to the ER for follow upMedDRA releases: 2024-11 · check-in free text available
-
2022-03-07
Report sent to call center — 3 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-03-11
- 2022-06-06
-
2022-11-17
Dose 3 — Pfizer-BioNTech
- 2022-12-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-12 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
| 3 | 2022-11-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Stomachache
Release 10 — day 14, dose 1, dependent
Symptoms: Headaches and vomiting.
Release 11 — 3 months, dose 2, dependent
Symptoms: Dehydration and fainting
Healthcare visit (other): Paramedics checked her and advised to take her to the ER for follow up
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | · | · | ✓ |
| SD | Dehydration | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Syncope | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Abdominal pain upper | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release